All In MedTech

FDA Clearance Tracker · P060039-S056

MEDTRONIC ATTAIN STARFIX MODEL 4195 LEADS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 4, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 4, 2014

Approved

Time to decision

178 days

Received Feb 7, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P060039-S056
Device name
MEDTRONIC ATTAIN STARFIX MODEL 4195 LEADS
Applicant location
Mounds View, MN
Received
Feb 7, 2014
Decided
Aug 4, 2014
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P060039

Device type

Device class
Class III

Every decision under product code OJX

FDA's approval statement

As written in FDA's record.

APPROVAL FOR UPDATING THE HEARTMATE II LVAS INSTRUCTIONS FOR USE TO INCLUDE THE POST-APPROVAL STUDY RESULTS FOR THE DESTINATION THERAPY INDICATION AND TO ADD A DISCUSSION ON PUMP THROMBOSIS.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.